Could your gut hold the key to beating cancer?

NCT ID NCT06050733

Summary

This study aims to understand how the community of bacteria in a person's gut (the microbiome) might affect how well their cancer responds to immunotherapy drugs. Researchers will compare the gut bacteria of patients whose cancer got worse during treatment to those who were stable or improved. They will also look for links between gut bacteria and common treatment side effects like fatigue and thinking problems.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Texas Medical Branch

    RECRUITING

    Galveston, Texas, 77845, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.